Deep Dive: Deep Dive Into New Presbyopia Therapies

Two new therapies for presbyopia are in the pipeline. Allergan recently submitted an NDA for its investigational eye drop to treat the condition, and Visus Therapeutics recently received FDA acceptance of its investigational new drug application for Brimochol. Dr. Michael Robinson from Allergan and Dr. Rhett Schiffman from Visus join Deep Dive to talk about how the products work and what’s coming next.